Breakthrough Therapy Designation Request

Expedited Programs for Serious Conditions-Drugs and Biologics

OMB: 0910-0765

IC ID: 209910

Documents and Forms
Information Collection (IC) Details

View Information Collection (IC)

Breakthrough Therapy Designation Request
 
No Modified
 
Required to Obtain or Retain Benefits
 
21 CFR 312; subpart E  (To search for a specific CFR, visit the Code of Federal Regulations.)

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Agency Guidance GFI Expedited Review for Serious conditions Contol No 0765.pdf No   Printable Only

Health Consumer Health and Safety

 

119 0
   
Private Sector Businesses or other for-profits
 
   100 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 156 0 0 43 0 113
Annual IC Time Burden (Hours) 10,920 0 0 3,010 0 7,910
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
No associated records found
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2022 OMB.report | Privacy Policy